KB
Kabita Baruah Medhi
About Kabita Baruah Medhi
Data last updated:
Kabita Baruah Medhi is a Director at Rebrace Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Rebrace Pharmaceuticals Private Limited reported revenue of ₹7.71 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rebrace Pharmaceuticals Private Limited U51909WB2020PTC238994 | Director | 20 Jan 2021 | 2020 | ₹7.71 Cr (FY 2024) | Active |
Board colleagues of Kabita Baruah Medhi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Neena Rasaily | 08838443 | Rebrace Pharmaceuticals Private Limited | Director |
| Rohit Swarnakar | 08467960 | Rebrace Pharmaceuticals Private Limited | Director |
| Sourami Saha | 10163532 | Rebrace Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kabita Baruah Medhi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kabita Baruah Medhi
Kabita Baruah Medhi currently holds 1 directorship: Rebrace Pharmaceuticals Private Limited (Director, since 20 Jan 2021, revenue ₹7.71 Cr (FY 2024)).
Kabita Baruah Medhi was first appointed on 20 Jan 2021 as Director at Rebrace Pharmaceuticals Private Limited.
The current boards of Kabita Baruah Medhi's companies include Neena Rasaily (Rebrace Pharmaceuticals Private Limited), Rohit Swarnakar (Rebrace Pharmaceuticals Private Limited), Sourami Saha (Rebrace Pharmaceuticals Private Limited).